AIMS: ) was designed, synthesized, and evaluated as potential aromatase inhibitors with anticancer activity. MATERIALS AND METHODS: ADMET profiling were performed for the selected
A systematic review synthesizing medicinal chemistry advances in quinoline derivatives for cancer therapy, providing design insights and identifying challenges rather than reporting primary clinical or preclinical data.